aceatherapeutics

ACEA Therapeutics (aceatherapeutics.com) is a clinical-stage biopharmaceutical company developing innovative small-molecule and antibody-drug-conjugate treatments across oncology, autoimmune, and antiviral therapeutic areas, with product candidates including Olgotrelvir, Abivertinib, AC0058, STI-6129, and AC0939. Surfaced as a portfolio company of Qiming Venture Partners and added to the API Evangelist network. As a pharmaceutical company oriented toward patients, physicians, and investors, ACEA Therapeutics publishes no public developer API, documentation, SDK, or technical integration surface at this time; this profile captures its verifiable web/domain footprint only.

aceatherapeutics is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Pharmaceuticals, Healthcare, and Oncology.

🌐 Visit website 📡 Source on GitHub

3.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0

0 APIs

CompanyBiopharmaceuticalPharmaceuticalsHealthcareOncologyLife SciencesDrug Development

Kin Score

Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0

Composite quality — 3.3/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.0 / 17

Access Clarity 0.0 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.1 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/aceatherapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: aceatherapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/aceatherapeutics.png
name: aceatherapeutics
description: ACEA Therapeutics (aceatherapeutics.com) is a clinical-stage biopharmaceutical company developing innovative
  small-molecule and antibody-drug-conjugate treatments across oncology, autoimmune, and antiviral therapeutic areas, with
  product candidates including Olgotrelvir, Abivertinib, AC0058, STI-6129, and AC0939. Surfaced as a portfolio company of
  Qiming Venture Partners and added to the API Evangelist network. As a pharmaceutical company oriented toward patients, physicians,
  and investors, ACEA Therapeutics publishes no public developer API, documentation, SDK, or technical integration surface
  at this time; this profile captures its verifiable web/domain footprint only.
url: https://raw.githubusercontent.com/api-evangelist/aceatherapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biopharmaceutical
- Pharmaceuticals
- Healthcare
- Oncology
- Life Sciences
- Drug Development
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/aceatherapeutics-domain-security.yml
- type: Website
  url: https://aceatherapeutics.com
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence

aceatherapeutics

Kin Score

Security Posture 1

Aceatherapeutics Domain Security

Resources

Access & Security 1

Company 1

Source (apis.yml)